Cargando…
Nano-curcumin therapy, a promising method in modulating inflammatory cytokines in COVID-19 patients
BACKGROUND: As an ongoing worldwide health issue, Coronavirus disease 2019 (COVID–19) has been causing serious complications, including pneumonia, acute respiratory distress syndrome (ARDS), and multi-organ failure. However, there is no decisive treatment approach available for this disorder, which...
Autores principales: | Valizadeh, Hamed, Abdolmohammadi-vahid, Samaneh, Danshina, Svetlana, Ziya Gencer, Mehmet, Ammari, Ali, Sadeghi, Armin, Roshangar, Leila, Aslani, Saeed, Esmaeilzadeh, Abdolreza, Ghaebi, Mahnaz, Valizadeh, Sepehr, Ahmadi, Majid |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7574843/ https://www.ncbi.nlm.nih.gov/pubmed/33129099 http://dx.doi.org/10.1016/j.intimp.2020.107088 |
Ejemplares similares
-
Immunomodulatory role of Nanocurcumin in COVID-19 patients with dropped natural killer cells frequency and function
por: Abbaspour-Aghdam, Sanaz, et al.
Publicado: (2022) -
Risk factors for adverse outcomes of COVID-19 patients: Possible basis for diverse responses to the novel coronavirus SARS-CoV-2
por: Ghaebi, Mahnaz, et al.
Publicado: (2021) -
Chronic obstructive pulmonary disease and asthma: mesenchymal stem cells and their extracellular vesicles as potential therapeutic tools
por: Abbaszadeh, Hossein, et al.
Publicado: (2022) -
Nanocurcumin improves Treg cell responses in patients with mild and severe SARS-CoV2
por: Tahmasebi, Safa, et al.
Publicado: (2021) -
Acute kidney injury in pregnant women following SARS-CoV-2 infection: A case report from Iran
por: Taghizadieh, Ali, et al.
Publicado: (2020)